1. Home
  2. BNTC vs DENN Comparison

BNTC vs DENN Comparison

Compare BNTC & DENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • DENN
  • Stock Information
  • Founded
  • BNTC 1995
  • DENN 1953
  • Country
  • BNTC United States
  • DENN United States
  • Employees
  • BNTC N/A
  • DENN N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • DENN Restaurants
  • Sector
  • BNTC Health Care
  • DENN Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • DENN Nasdaq
  • Market Cap
  • BNTC 366.6M
  • DENN 203.4M
  • IPO Year
  • BNTC N/A
  • DENN 1989
  • Fundamental
  • Price
  • BNTC $12.68
  • DENN $4.42
  • Analyst Decision
  • BNTC Strong Buy
  • DENN Strong Buy
  • Analyst Count
  • BNTC 6
  • DENN 6
  • Target Price
  • BNTC $23.83
  • DENN $7.46
  • AVG Volume (30 Days)
  • BNTC 228.2K
  • DENN 524.9K
  • Earning Date
  • BNTC 05-14-2025
  • DENN 07-29-2025
  • Dividend Yield
  • BNTC N/A
  • DENN N/A
  • EPS Growth
  • BNTC N/A
  • DENN N/A
  • EPS
  • BNTC N/A
  • DENN 0.33
  • Revenue
  • BNTC N/A
  • DENN $453,997,000.00
  • Revenue This Year
  • BNTC N/A
  • DENN $7.51
  • Revenue Next Year
  • BNTC N/A
  • DENN $1.98
  • P/E Ratio
  • BNTC N/A
  • DENN $13.41
  • Revenue Growth
  • BNTC N/A
  • DENN N/A
  • 52 Week Low
  • BNTC $7.05
  • DENN $2.85
  • 52 Week High
  • BNTC $17.15
  • DENN $7.73
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 44.12
  • DENN 57.09
  • Support Level
  • BNTC $12.57
  • DENN $4.30
  • Resistance Level
  • BNTC $13.65
  • DENN $4.71
  • Average True Range (ATR)
  • BNTC 1.18
  • DENN 0.18
  • MACD
  • BNTC -0.11
  • DENN 0.02
  • Stochastic Oscillator
  • BNTC 43.95
  • DENN 61.69

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About DENN Denny's Corporation

Denny's Corp is one of America's franchised full-service restaurant chains based on the number of restaurants. The company owns and operates the Denny's brand and the Keke's Breakfast Cafe brand. It provides Pancakes, Appetizers & Soups, Sandwiches & Salads, Breakfast Melts, Omelets, and others. The company generates its revenue from two sources: the sale of food and beverages and the collection of royalties, advertising revenue, initial and other fees, including occupancy revenue, from restaurants operated by their franchisees.

Share on Social Networks: